ZDHHC13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.609000E-01
Normal-vs-Stage2
4.197000E-01
Normal-vs-Stage3
3.907400E-01
Normal-vs-Stage4
5.711600E-01
Stage1-vs-Stage2
8.604200E-01
Stage1-vs-Stage3
1.222190E-01
Stage1-vs-Stage4
9.568000E-01
Stage2-vs-Stage3
1.135750E-01
Stage2-vs-Stage4
8.393400E-01
Stage3-vs-Stage4
2.073600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.328400E-01
Normal-vs-AfricanAmerican
5.015400E-01
Normal-vs-Asian
4.537200E-01
Caucasian-vs-AfricanAmerican
7.639800E-01
Caucasian-vs-Asian
6.301400E-01
AfricanAmerican-vs-Asian
6.361400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.653400E-01
Normal-vs-Female
5.213000E-01
Male-vs-Female
7.150300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.395000E-01
Normal-vs-Age(41-60Yrs)
3.054000E-01
Normal-vs-Age(61-80Yrs)
4.801600E-01
Normal-vs-Age(81-100Yrs)
7.005400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.966400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.366400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.281200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.686000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.735400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.380600E-01
Normal-vs-Daily Drinker
5.164400E-01
Normal-vs-Weekly Drinker
8.010800E-01
Normal-vs-Occasional Drinker
8.740000E-02
Normal-vs-Social Drinker
3.674800E-01
Non Drinker-vs-Daily Drinker
8.800000E-01
Non Drinker-vs-Weekly Drinker
1.294840E-01
Non Drinker-vs-Occasional Drinker
2.347900E-02
Non Drinker-vs-Social Drinker
9.308600E-01
Daily Drinker-vs-Weekly Drinker
1.092240E-01
Daily Drinker-vs-Occasional Drinker
2.360200E-02
Daily Drinker-vs-Social Drinker
7.796200E-01
Weekly Drinker-vs-Occasional Drinker
5.808000E-04
Weekly Drinker-vs-Social Drinker
7.231500E-02
Occasional Drinker-vs-Social Drinker
7.463800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.606000E-02
Normal-vs-Grade 2
6.100000E-02
Normal-vs-Grade 3
6.160000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.097400E-01
Grade 1-vs-Grade 3
5.503800E-01
Grade 1-vs-Grade 4
5.606000E-02
Grade 2-vs-Grade 3
8.175000E-01
Grade 2-vs-Grade 4
6.100000E-02
Grade 3-vs-Grade 4
6.160000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.859600E-01
Normal-vs-NonDiabetic
3.924600E-01
Diabetic-vs-NonDiabetic
5.341200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.606800E-01
Normal-vs-NoPancreatitis
4.697000E-01
Pancreatitis-vs-NoPancreatitis
7.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.233400E-01
Normal-vs-N1
4.671400E-01
N0-vs-N1
2.134800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.283970E-01
Normal-vs-TP53-NonMutant
4.704000E-01
TP53-Mutant-vs-TP53-NonMutant
2.552000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
